ArticleDysphagia2026
Validity of Aspiration Prevention Surgery in Elderly Patients with Cerebrovascular or Neurodegenerative Disorders.
Article in Dysphagia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The risk of aspiration pneumonia has been reported to increase with age, especially in frail elderly patients with cerebrovascular and/or neurodegenerative disorders. To prevent this type of pneumonia, aspiration prevention surgery (APS) procedures have been demonstrated to be effective. However, the comprehensive efficacy of APS, not only in terms of survival rates, but also in terms of medical costs and caregiver burden, has not been fully evaluated in elderly patients requiring aspiration care. Thus, the aim of the current study was to demonstrate the validity of APS in elderly patients with cerebrovascular or neurodegenerative disorders. A total of 135 patients were enrolled; 82 with cerebrovascular disorders and 53 with neurodegenerative disorders, in whom APS was applied to 52 and 36 patients, respectively. The 2-year survival rates, medical costs, and number of suctioning procedures as a measure of caregiver burden were investigated in patients treated with APS (the APS group) and those without APS (the non-APS group). The 2-year survival rates for all patients were 53.4% in the APS group and 4.3% in the non-APS group. This result showed significantly better outcomes in the APS group. Moreover, in the APS group, the postoperative suction frequency showed a significant decrease compared to the preoperative suction frequency. Finally, medical costs were significantly lower in the APS group compared to the non-APS group. The results of this study demonstrate that APS contributed to improved survival rates, reduced medical costs, and a decrease in suctioning frequency in elderly patients with cerebrovascular or neurodegenerative diseases.
Indexed as
Identifiers
40965646What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.